Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, ...

(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Griffin voiced his concern over Trump's approach towards tariffs, stating that the "bombastic rhetoric" has already caused ...

Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...

Tech stocks can be quite volatile, and this one looks particularly expensive. So, what can you buy instead? The post ...

Ken Griffin, founder of investment firm Citadel, warned Tuesday that President ... at the time received a hero's welcome at the New York Stock Exchange when he visited in December.

For President Trump, tariffs are a way of protecting American industries and safeguarding national security. For Tracy ...